Back to companies

PORTFOLIO

Perfuze

Perfuze is developing innovative catheter technology to treat acute ischemic stroke. The technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy.

Milestones

Founded: 2018 Invested: 2018

Leadership Team

Wayne Allen Liam Mullins

HQ

Galway, Ireland

Earlybird Lead

OUR PORTFOLIO

OUR PORTFOLIO

SIMILAR COMPANIES

SIMILAR COMPANIES

SIMILAR COMPANIES

Meet the companies we’ve backed on their way to creating groundbreaking change.

Meet the companies we’ve backed on their way to creating groundbreaking change.

WE INVEST BECAUSE
WE BELIEVE

Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.